These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 10470169

  • 1. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
    Lamerz R, Stoetzer OJ, Mezger J, Brandt A, Darsow M, Wilmanns W.
    Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169
    [Abstract] [Full Text] [Related]

  • 2. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H, Rona G, Hutter C, Bayer PM, Kummer F.
    Wien Klin Wochenschr; 1986 Sep 12; 98(17):564-73. PubMed ID: 3020811
    [Abstract] [Full Text] [Related]

  • 3. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
    Kyrkou KA, Iatridis SG, Athanassiadou PP, Athanassiadis PP, Mandragos CE.
    Cancer Detect Prev; 1985 Sep 12; 8(1-2):247-54. PubMed ID: 4064045
    [Abstract] [Full Text] [Related]

  • 4. [Diagnostic value of tumor markers in pleural effusions].
    Botte G, Laferrere L, Etchepare S, Dalurzo D, Duhart JE, Adaro FV.
    Medicina (B Aires); 1990 Sep 12; 50(3):213-6. PubMed ID: 2130207
    [Abstract] [Full Text] [Related]

  • 5. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ, De Miguel J, García Díaz JD, Díez M.
    Anticancer Res; 2008 Sep 12; 28(5B):2947-52. PubMed ID: 19031938
    [Abstract] [Full Text] [Related]

  • 6. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM, Bernstein LH, Brogan DA, Criscuolo EM.
    Acta Cytol; 1987 Sep 12; 31(2):113-8. PubMed ID: 3548190
    [Abstract] [Full Text] [Related]

  • 7. New approaches in the diagnostic procedure of malignant pleural effusions.
    Terracciano D, Di Carlo A, Papa P, Cicalese M, Maietta P, Cecere C, Mariano A, Macchia V.
    Oncol Rep; 2004 Jul 12; 12(1):79-83. PubMed ID: 15201963
    [Abstract] [Full Text] [Related]

  • 8. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
    Gulyás M, Elek G, Molnár M, Szollár L.
    Orv Hetil; 1995 Nov 05; 136(45):2453-8. PubMed ID: 8524550
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
    Huang WW, Tsao SM, Lai CL, Su CC, Tseng CE.
    Pathology; 2010 Apr 05; 42(3):224-8. PubMed ID: 20350214
    [Abstract] [Full Text] [Related]

  • 10. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
    Porcel JM, Salud A, Vives M, Esquerda A, Rodríguez-Panadero F.
    Clin Biochem; 2005 Nov 05; 38(11):1031-3. PubMed ID: 15925354
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology.
    Whiteside TL, Dekker A.
    Acta Cytol; 1979 Nov 05; 23(6):443-8. PubMed ID: 295160
    [Abstract] [Full Text] [Related]

  • 12. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F, Fukuoka M, Takada M, Tamai S, Sakai N, Negoro S, Okunaka N, Sone S, Tsubura E.
    Jpn J Clin Oncol; 1984 Sep 05; 14(3):321-7. PubMed ID: 6090732
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M, Chondros K, Ferderigos AS, Daganou M, Dema A, Dalamaga A, Kakari S, Stringou E.
    Anticancer Res; 1992 Sep 05; 12(4):1267-70. PubMed ID: 1503419
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].
    Yang Z, Xie C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr 05; 24(4):201-3. PubMed ID: 11802962
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions.
    Pinto MM, Bernstein LH, Rudolph RA, Brogan DA, Rosman M.
    Arch Pathol Lab Med; 1992 Jun 05; 116(6):626-31. PubMed ID: 1616424
    [Abstract] [Full Text] [Related]

  • 16. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion.
    Sthaneshwar P, Yap SF, Jayaram G.
    Malays J Pathol; 2002 Jun 05; 24(1):53-8. PubMed ID: 16329556
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of three tumor markers determined in pleural effusions.
    Conejo JR, Benedito JE, Jimenez A, Menchen M, Cano J, Granizo V, Larrodera L.
    Eur J Clin Chem Clin Biochem; 1996 Feb 05; 34(2):139-42. PubMed ID: 8833646
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
    Miédougé M, Rouzaud P, Salama G, Pujazon MC, Vincent C, Mauduyt MA, Reyre J, Carles P, Serre G.
    Br J Cancer; 1999 Nov 05; 81(6):1059-65. PubMed ID: 10576665
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.